Psychedelic Drug Development Pipeline Updates (Q1’25)
This review of significant changes, additions, and removals to the Bullseye Chart is exclusively for Pα+ subscribers.
If you're not yet a subscriber, you can still view the Bullseye Chart and our Psychedelic Drug Development Tracker...
Join Today
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.
- Regular Bulletins featuring news, analysis, and research
- Articles and deep dives across psychedelic drug development, policy, and research
- Exclusive interviews with researchers, executives, and policymakers
- Bespoke resources and tools including the Psychedelic Bill Tracker
- Quarterly video briefings and slide decks
Already a member?
Sign In